Profil
Mark Heiman worked as a Principal at Eli Lilly & Co. and as an Assistant Professor at Tulane University.
He was also the Chief Scientific Officer & Vice President-Research at MicroBiome Therapeutics LLC from 2013 to 2018.
He received his undergraduate degree from the University of New Orleans and his doctorate from LSU Medical School.
Ehemalige bekannte Positionen von Mark Heiman
| Unternehmen | Position | Ende |
|---|---|---|
MicroBiome Therapeutics LLC
 MicroBiome Therapeutics LLC Pharmaceuticals: MajorHealth Technology MicroBiome Therapeutics LLC develops drug therapies for metabolic diseases. Its microbiome modulators are designed to augment the growth of certain desirable bacterial strains and discourage the growth of others. The company was founded by John B. Elstrott and Dale R. Pfost in 2009 and is headquartered in New Orleans, LA. | Technik-/Wissenschafts-/F&E-Leiter | 02.01.2018 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
| Tulane University (Louisiana) | Corporate Officer/Principal | - |
Ausbildung von Mark Heiman
| University of New Orleans | Undergraduate Degree |
| Lsu Medical School | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| Private Unternehmen | 1 |
|---|---|
MicroBiome Therapeutics LLC
MicroBiome Therapeutics LLC Pharmaceuticals: MajorHealth Technology MicroBiome Therapeutics LLC develops drug therapies for metabolic diseases. Its microbiome modulators are designed to augment the growth of certain desirable bacterial strains and discourage the growth of others. The company was founded by John B. Elstrott and Dale R. Pfost in 2009 and is headquartered in New Orleans, LA. | Health Technology |
